BioSenic S.A. (BIOS) — Cash Flow-to-Debt Ratio
BioSenic S.A. (BIOS) has a Cash Flow-to-Debt Ratio of -0.04x as of December 2024, meaning its operating cash flow of €-1.39 Million could theoretically repay 0% of its total liabilities (€31.55 Million) in one year. Explore long-term investment intensity of BioSenic S.A. to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BioSenic S.A. Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for BioSenic S.A. across 13 annual periods. Also explore BIOS total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for BioSenic S.A. (2012–2024)
Year-by-year debt coverage analysis for BioSenic S.A.. For market capitalisation and broader financial context, see BioSenic S.A. (BIOS) total market value.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.07x | €-2.23 Million | €31.55 Million | ▲ +34.2% |
| 2023 | -0.11x | €-3.47 Million | €32.26 Million | ▼ -47.5% |
| 2022 | -0.07x | €-1.91 Million | €26.20 Million | ▲ +84.9% |
| 2021 | -0.48x | €-12.78 Million | €26.54 Million | ▲ +35.6% |
| 2020 | -0.75x | €-16.08 Million | €21.51 Million | ▼ -46.3% |
| 2019 | -0.51x | €-10.40 Million | €20.34 Million | ▲ +15.8% |
| 2018 | -0.61x | €-12.90 Million | €21.26 Million | ▼ -25.5% |
| 2017 | -0.48x | €-11.02 Million | €22.79 Million | ▲ +0.9% |
| 2016 | -0.49x | €-11.37 Million | €23.32 Million | ▲ +7.8% |
| 2015 | -0.53x | €-11.77 Million | €22.24 Million | ▼ -405.8% |
| 2014 | -0.10x | €-3.52 Million | €33.69 Million | ▲ +59.3% |
| 2013 | -0.26x | €-3.27 Million | €12.75 Million | ▲ +25.3% |
| 2012 | -0.34x | €-4.05 Million | €11.78 Million | — |